Not Rated
|
Fund Size
(0% of Investment in Category)
|
Expense Ratio
(0.53% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 11-Nov-25 | 10067.60 | 0.68% | - | 0.37% | 105/353 |
| 1 Month | 17-Oct-25 | 9910.60 | -0.89% | - | 0.81% | 341/352 |
| 3 Month | 18-Aug-25 | 9976.00 | -0.24% | - | 3.45% | 335/342 |
| 6 Month | 16-May-25 | 10473.10 | 4.73% | - | 4.36% | 87/319 |
| YTD | 01-Jan-25 | 9759.20 | -2.41% | - | 6.82% | 244/282 |
| 1 Year | 18-Nov-24 | 10520.40 | 5.20% | 5.20% | 8.72% | 202/261 |
| Since Inception | 09-Sep-24 | 10202.10 | 2.02% | 1.69% | 10.32% | 307/340 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 18-Nov-24 | 12000 | 12369.71 | 3.08 % | 5.74 % |
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 24.2 | 13.22% | 0.41% | 15.66% (Apr 2025) | 12.79% (Aug 2025) | 14.32 k | 71.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 11.7 | 6.37% | 0.85% | 6.62% (May 2025) | 5.52% (Sep 2025) | 1.73 k | 8.00 |
| Max Healthcare Institute Ltd. | Hospital | 11.5 | 6.29% | 0.02% | 7.1% (Jun 2025) | 5.62% (Nov 2024) | 10.02 k | 50.00 |
| Cipla Ltd. | Pharmaceuticals | 11.4 | 6.20% | -0.17% | 7.01% (Feb 2025) | 6.2% (Oct 2025) | 7.56 k | 38.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 10.5 | 5.73% | 0.06% | 5.82% (Aug 2025) | 5.35% (Nov 2024) | 1.37 k | 7.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 9.9 | 5.41% | -0.26% | 6.35% (Dec 2024) | 5.41% (Oct 2025) | 8.26 k | 41.00 |
| Fortis Healthcare Ltd. | Hospital | 7.2 | 3.95% | 0.11% | 3.95% (Oct 2025) | 2.67% (Nov 2024) | 7.07 k | 36.00 |
| - Lupin Ltd. | Pharmaceuticals | 6.5 | 3.52% | 0.00% | 4.27% (Dec 2024) | 3.47% (Jul 2025) | 3.28 k | 16.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 5.1 | 2.77% | -0.10% | 2.92% (Jul 2025) | 2.39% (Dec 2024) | 1.42 k | 7.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 5 | 2.75% | 0.26% | 2.75% (Oct 2025) | 1.73% (Nov 2024) | 5.27 k | 26.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.92% |
| Margin | Margin | 0.01% |
| Net Receivables | Net Receivables | -1.81% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 89 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 5 is/are ranked 4 * , 11 is/are ranked 3 * , 5 is/are ranked 2 * , 1 is/are ranked 1 * , and 61 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Bandhan Liquid Fund - Regular Plan - Growth | 4 | 18114.52 | 0.49 | 1.42 | 2.93 | 6.55 | 6.92 |
| Bandhan Small Cap Fund - Regular Plan - Growth | 5 | 17380.29 | 1.91 | 3.78 | 7.97 | 7.92 | 31.45 |
| Bandhan Corporate Bond Fund - Regular Plan - Growth | 5 | 15704.65 | 0.38 | 1.54 | 2.53 | 7.90 | 7.40 |
| Bandhan Money Market Fund - Regular Plan - Growth | 1 | 14372.30 | 0.52 | 1.47 | 3.27 | 7.44 | 7.07 |
| Bandhan Banking and PSU Fund - Regular Plan - Growth | 4 | 12963.49 | 0.39 | 1.49 | 2.56 | 7.58 | 7.26 |
| Bandhan Large & Mid Cap Fund - Regular Plan - Growth | 5 | 11799.16 | 2.10 | 5.37 | 8.34 | 12.57 | 23.88 |
| Bandhan Bond Fund - Short Term - Regular Plan - Growth | 5 | 10766.48 | 0.39 | 1.56 | 2.59 | 8.01 | 7.50 |
| Bandhan Value Fund - Regular Plan - Growth | 2 | 10302.01 | 1.25 | 3.58 | 3.15 | 5.67 | 18.04 |
| Bandhan Arbitrage Fund - Regular Plan - Growth | 3 | 8747.55 | 0.46 | 1.38 | 2.86 | 6.26 | 7.02 |
| Bandhan Flexi Cap Fund - Regular Plan - Growth | 3 | 7645.00 | 1.10 | 2.91 | 4.78 | 10.74 | 15.45 |